CLINICAL_TRIALS
trial_result
· 2014-03-14
Clinical Trial Update: Dose-Intense Temozolomide in Recurrent Glioblastoma [Phase 2]
Summary
Phase 2 trial assessing a dose-intensive temozolomide regimen in patients with recurrent glioblastoma and gliosarcoma; results were posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Patrick Y. Wen, MD | Conditions: Glioblastoma, Gliosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2014-03-14